Tc-99m Sestamibi Myocardial Perfusion Imaging After Coronary Artery Bypass Grafting for Ischemic Heart Failure

Area of Science:

• Cardiology
• Nuclear Medicine
• Cardiac Surgery

Background:

• Ischemic heart failure (HF) significantly impacts patient morbidity and mortality.
• The optimal treatment strategy for ischemic HF, particularly revascularization versus medical management, remains debated.
• Assessing treatment efficacy requires objective measures of myocardial perfusion and function.

Purpose of the Study:

• To evaluate the impact of coronary artery bypass grafting (CABG) on myocardial ischemia and left ventricular function in a patient with ischemic heart failure.
• To investigate the role of Tc-99m sestamibi myocardial perfusion imaging in assessing treatment response.
• To provide evidence supporting the benefits of revascularization in ischemic heart failure.

Main Methods:

• A single patient diagnosed with ischemic heart failure underwent Tc-99m sestamibi myocardial perfusion imaging.
• Imaging was performed preoperatively and three months after undergoing coronary artery bypass grafting (CABG).
• Quantitative and qualitative analysis of myocardial perfusion and left ventricular systolic function was conducted.

Main Results:

• Post-CABG imaging demonstrated a significant reduction in the degree and extent of myocardial ischemia.
• Left ventricular systolic function showed significant improvement compared to preoperative assessments.
• Tc-99m sestamibi imaging effectively visualized the positive changes following revascularization.

Conclusions:

• Coronary artery bypass grafting led to substantial improvements in myocardial perfusion and cardiac function in this patient with ischemic heart failure.
• Revascularization should be considered a beneficial therapeutic option for selected patients with ischemic heart failure.
• Myocardial radionuclide imaging is a valuable tool for assessing the outcomes of revascularization in ischemic heart disease.